FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1925829613> ?p ?o ?g. }

• W1925829613 endingPage "e0128662" @default.
• W1925829613 startingPage "e0128662" @default.
• W1925829613 abstract "To identify predictive biomarkers for clinical responses to bortezomib treatment, 0.06 mL of each whole blood without any cell separation procedures was stimulated ex vivo using five agents, and eight mRNAs were quantified. In six centers, heparinized peripheral blood was prospectively obtained from 80 previously treated or untreated, symptomatic multiple myeloma (MM) patients with measurable levels of M-proteins. The blood sample was procured prior to treatment as well as 2-3 days and 1-3 weeks after the first dose of bortezomib, which was intravenously administered biweekly or weekly, during the first cycle. Six stimulant-mRNA combinations; that is, lipopolysaccharide (LPS)-granulocyte-macrophage colony-stimulating factor (GM-CSF), LPS-CXCL chemokine 10 (CXCL10), LPS-CCL chemokine 4 (CCL4), phytohemagglutinin-CCL4, zymosan A (ZA)-GMCSF and ZA-CCL4 showed significantly higher induction in the complete and very good partial response group than in the stable and progressive disease group, as determined by both parametric (t-test) and non-parametric (unpaired Mann-Whitney test) tests. Moreover, LPS-induced CXCL10 mRNA expression was significantly suppressed 2-3 days after the first dose of bortezomib in all patients, as determined by both parametric (t-test) and non-parametric (paired Wilcoxon test) tests, whereas the complete and very good partial response group showed sustained suppression 1-3 weeks after the first dose. Thus, pretreatment LPS-CXCL10 mRNA and/or the six combinations may serve as potential biomarkers for the response to bortezomib treatment in MM patients." @default.
• W1925829613 created "2016-06-24" @default.
• W1925829613 creator A5005974922 @default.
• W1925829613 creator A5013090266 @default.
• W1925829613 creator A5013490553 @default.
• W1925829613 creator A5014431889 @default.
• W1925829613 creator A5018501206 @default.
• W1925829613 creator A5025061047 @default.
• W1925829613 creator A5030682087 @default.
• W1925829613 creator A5062155311 @default.
• W1925829613 creator A5069130284 @default.
• W1925829613 creator A5078852881 @default.
• W1925829613 creator A5080272522 @default.
• W1925829613 creator A5088707445 @default.
• W1925829613 date "2015-06-26" @default.
• W1925829613 modified "2023-09-24" @default.
• W1925829613 title "Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma" @default.
• W1925829613 cites W1592113356 @default.
• W1925829613 cites W1969648097 @default.
• W1925829613 cites W1972201331 @default.
• W1925829613 cites W1974005261 @default.
• W1925829613 cites W1983706317 @default.
• W1925829613 cites W1983715506 @default.
• W1925829613 cites W1985021407 @default.
• W1925829613 cites W1989750981 @default.
• W1925829613 cites W1993549070 @default.
• W1925829613 cites W1995574992 @default.
• W1925829613 cites W2004010323 @default.
• W1925829613 cites W2017937681 @default.
• W1925829613 cites W2044436186 @default.
• W1925829613 cites W2055338149 @default.
• W1925829613 cites W2059733579 @default.
• W1925829613 cites W2070790769 @default.
• W1925829613 cites W2071202661 @default.
• W1925829613 cites W2071434932 @default.
• W1925829613 cites W2079138963 @default.
• W1925829613 cites W2080154563 @default.
• W1925829613 cites W2082682074 @default.
• W1925829613 cites W2083203854 @default.
• W1925829613 cites W2086653135 @default.
• W1925829613 cites W2088765731 @default.
• W1925829613 cites W2096207943 @default.
• W1925829613 cites W2101576302 @default.
• W1925829613 cites W2103289287 @default.
• W1925829613 cites W2104039873 @default.
• W1925829613 cites W2104634390 @default.
• W1925829613 cites W2108235071 @default.
• W1925829613 cites W2108826965 @default.
• W1925829613 cites W2109476525 @default.
• W1925829613 cites W2110466835 @default.
• W1925829613 cites W2110486997 @default.
• W1925829613 cites W2111650326 @default.
• W1925829613 cites W2117172636 @default.
• W1925829613 cites W2119584679 @default.
• W1925829613 cites W2119682802 @default.
• W1925829613 cites W2120780398 @default.
• W1925829613 cites W2124560610 @default.
• W1925829613 cites W2134902298 @default.
• W1925829613 cites W2142368474 @default.
• W1925829613 cites W2150878522 @default.
• W1925829613 cites W2162468902 @default.
• W1925829613 cites W2166508172 @default.
• W1925829613 cites W2171504422 @default.
• W1925829613 cites W2172122039 @default.
• W1925829613 doi "https://doi.org/10.1371/journal.pone.0128662" @default.
• W1925829613 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4482752" @default.
• W1925829613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26115406" @default.
• W1925829613 hasPublicationYear "2015" @default.
• W1925829613 type Work @default.
• W1925829613 sameAs 1925829613 @default.
• W1925829613 citedByCount "2" @default.
• W1925829613 countsByYear W19258296132020 @default.
• W1925829613 countsByYear W19258296132021 @default.
• W1925829613 crossrefType "journal-article" @default.
• W1925829613 hasAuthorship W1925829613A5005974922 @default.
• W1925829613 hasAuthorship W1925829613A5013090266 @default.
• W1925829613 hasAuthorship W1925829613A5013490553 @default.
• W1925829613 hasAuthorship W1925829613A5014431889 @default.
• W1925829613 hasAuthorship W1925829613A5018501206 @default.
• W1925829613 hasAuthorship W1925829613A5025061047 @default.
• W1925829613 hasAuthorship W1925829613A5030682087 @default.
• W1925829613 hasAuthorship W1925829613A5062155311 @default.
• W1925829613 hasAuthorship W1925829613A5069130284 @default.
• W1925829613 hasAuthorship W1925829613A5078852881 @default.
• W1925829613 hasAuthorship W1925829613A5080272522 @default.
• W1925829613 hasAuthorship W1925829613A5088707445 @default.
• W1925829613 hasBestOaLocation W19258296131 @default.
• W1925829613 hasConcept C126322002 @default.
• W1925829613 hasConcept C13373296 @default.
• W1925829613 hasConcept C137061746 @default.
• W1925829613 hasConcept C150903083 @default.
• W1925829613 hasConcept C1621761 @default.
• W1925829613 hasConcept C16685009 @default.
• W1925829613 hasConcept C202751555 @default.
• W1925829613 hasConcept C203014093 @default.
• W1925829613 hasConcept C207001950 @default.
• W1925829613 hasConcept C26291073 @default.
• W1925829613 hasConcept C2776364478 @default.

• next